vs
嘉德诺（BTSG）与PILGRIMS PRIDE CORP（PPC）财务数据对比。点击上方公司名可切换其他公司
PILGRIMS PRIDE CORP的季度营收约是嘉德诺的1.3倍（$4.5B vs $3.6B），嘉德诺净利率更高（2.2% vs 1.9%，领先0.2%），嘉德诺同比增速更快（16.3% vs 3.3%），嘉德诺自由现金流更多（$193.9M vs $10.0M），过去两年嘉德诺的营收复合增速更高（17.4% vs 1.8%）
嘉德诺是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品与医疗产品分销，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医用外科用品，还运营着规模位居前列的放射性药物网络。
Pilgrim's Pride是美国跨国食品企业，为美国及波多黎各最大的鸡肉生产商之一，同时是墨西哥第二大鸡肉生产商。公司2009年12月脱离破产状态，2011年将美国总部迁至科罗拉多州格里利，由JBS集团控股，2016年11月底以3.5亿美元收购Gold'n Plump。
BTSG vs PPC — 直观对比
营收规模更大
PPC
是对方的1.3倍
$3.6B
营收增速更快
BTSG
高出13.0%
3.3%
净利率更高
BTSG
高出0.2%
1.9%
自由现金流更多
BTSG
多$183.9M
$10.0M
两年增速更快
BTSG
近两年复合增速
1.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6B | $4.5B |
| 净利润 | $77.1M | $88.0M |
| 毛利率 | 11.6% | 9.5% |
| 营业利润率 | 3.0% | 4.5% |
| 净利率 | 2.2% | 1.9% |
| 营收同比 | 16.3% | 3.3% |
| 净利润同比 | 381.8% | -62.7% |
| 每股收益（稀释后） | $0.34 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BTSGPPC
| Q4 25 | $3.6B | $4.5B | ||
| Q3 25 | $3.3B | $4.8B | ||
| Q2 25 | $3.1B | $4.8B | ||
| Q1 25 | $2.9B | $4.5B | ||
| Q4 24 | $3.1B | $4.4B | ||
| Q3 24 | $2.9B | $4.6B | ||
| Q2 24 | $2.7B | $4.6B | ||
| Q1 24 | $2.6B | $4.4B |
净利润BTSGPPC
| Q4 25 | $77.1M | $88.0M | ||
| Q3 25 | $55.8M | $342.8M | ||
| Q2 25 | $28.2M | $355.5M | ||
| Q1 25 | $29.5M | $296.0M | ||
| Q4 24 | $16.0M | $235.9M | ||
| Q3 24 | $-8.2M | $349.9M | ||
| Q2 24 | $19.9M | $326.3M | ||
| Q1 24 | $-45.8M | $174.4M |
毛利率BTSGPPC
| Q4 25 | 11.6% | 9.5% | ||
| Q3 25 | 11.8% | 13.9% | ||
| Q2 25 | 11.9% | 15.0% | ||
| Q1 25 | 11.8% | 12.4% | ||
| Q4 24 | 13.8% | 12.7% | ||
| Q3 24 | 14.0% | 14.9% | ||
| Q2 24 | 14.2% | 15.2% | ||
| Q1 24 | 14.3% | 8.8% |
营业利润率BTSGPPC
| Q4 25 | 3.0% | 4.5% | ||
| Q3 25 | 2.6% | 10.4% | ||
| Q2 25 | 1.5% | 10.8% | ||
| Q1 25 | 1.8% | 9.1% | ||
| Q4 24 | 2.6% | 7.0% | ||
| Q3 24 | 2.0% | 11.1% | ||
| Q2 24 | 2.3% | 9.7% | ||
| Q1 24 | 0.3% | 5.7% |
净利率BTSGPPC
| Q4 25 | 2.2% | 1.9% | ||
| Q3 25 | 1.7% | 7.2% | ||
| Q2 25 | 0.9% | 7.5% | ||
| Q1 25 | 1.0% | 6.6% | ||
| Q4 24 | 0.5% | 5.4% | ||
| Q3 24 | -0.3% | 7.6% | ||
| Q2 24 | 0.7% | 7.2% | ||
| Q1 24 | -1.8% | 4.0% |
每股收益（稀释后）BTSGPPC
| Q4 25 | $0.34 | $0.37 | ||
| Q3 25 | $0.26 | $1.44 | ||
| Q2 25 | $0.13 | $1.49 | ||
| Q1 25 | $0.14 | $1.24 | ||
| Q4 24 | $0.11 | $1.00 | ||
| Q3 24 | $-0.04 | $1.47 | ||
| Q2 24 | $0.10 | $1.37 | ||
| Q1 24 | $-0.26 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.4M | $640.2M |
| 总债务越低越好 | $2.5B | $3.1B |
| 股东权益账面价值 | $1.9B | $3.7B |
| 总资产 | $6.4B | $10.3B |
| 负债/权益比越低杠杆越低 | 1.34× | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资BTSGPPC
| Q4 25 | $88.4M | $640.2M | ||
| Q3 25 | $140.3M | $612.6M | ||
| Q2 25 | $70.1M | $849.0M | ||
| Q1 25 | $52.3M | $2.1B | ||
| Q4 24 | $61.3M | $2.0B | ||
| Q3 24 | $36.0M | $1.9B | ||
| Q2 24 | $25.0M | $1.3B | ||
| Q1 24 | $58.0M | $870.8M |
总债务BTSGPPC
| Q4 25 | $2.5B | $3.1B | ||
| Q3 25 | $2.5B | $3.1B | ||
| Q2 25 | $2.5B | $3.1B | ||
| Q1 25 | $2.5B | $3.2B | ||
| Q4 24 | $2.6B | $3.2B | ||
| Q3 24 | $2.7B | $3.2B | ||
| Q2 24 | $2.6B | $3.2B | ||
| Q1 24 | $2.6B | $3.3B |
股东权益BTSGPPC
| Q4 25 | $1.9B | $3.7B | ||
| Q3 25 | $1.8B | $3.5B | ||
| Q2 25 | $1.7B | $3.7B | ||
| Q1 25 | $1.7B | $3.1B | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $1.6B | $4.2B | ||
| Q2 24 | $1.6B | $3.7B | ||
| Q1 24 | $1.6B | $3.5B |
总资产BTSGPPC
| Q4 25 | $6.4B | $10.3B | ||
| Q3 25 | $6.0B | $10.0B | ||
| Q2 25 | $5.9B | $10.1B | ||
| Q1 25 | $5.8B | $11.0B | ||
| Q4 24 | $5.9B | $10.7B | ||
| Q3 24 | $5.8B | $10.7B | ||
| Q2 24 | $5.6B | $10.1B | ||
| Q1 24 | $5.7B | $9.8B |
负债/权益比BTSGPPC
| Q4 25 | 1.34× | 0.84× | ||
| Q3 25 | 1.38× | 0.87× | ||
| Q2 25 | 1.45× | 0.83× | ||
| Q1 25 | 1.50× | 1.02× | ||
| Q4 24 | 1.58× | 0.76× | ||
| Q3 24 | 1.65× | 0.76× | ||
| Q2 24 | 1.63× | 0.85× | ||
| Q1 24 | 1.64× | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $231.6M | $291.2M |
| 自由现金流经营现金流 - 资本支出 | $193.9M | $10.0M |
| 自由现金流率自由现金流/营收 | 5.5% | 0.2% |
| 资本支出强度资本支出/营收 | 1.1% | 6.2% |
| 现金转化率经营现金流/净利润 | 3.00× | 3.31× |
| 过去12个月自由现金流最近4个季度 | $394.7M | $653.1M |
8季度趋势，按日历期对齐
经营现金流BTSGPPC
| Q4 25 | $231.6M | $291.2M | ||
| Q3 25 | $107.9M | $458.3M | ||
| Q2 25 | $49.1M | $495.2M | ||
| Q1 25 | $101.6M | $126.9M | ||
| Q4 24 | $90.6M | $349.3M | ||
| Q3 24 | $27.2M | $651.1M | ||
| Q2 24 | $-15.2M | $718.6M | ||
| Q1 24 | $-78.9M | $271.0M |
自由现金流BTSGPPC
| Q4 25 | $193.9M | $10.0M | ||
| Q3 25 | $92.2M | $275.9M | ||
| Q2 25 | $24.7M | $339.1M | ||
| Q1 25 | $84.0M | $28.1M | ||
| Q4 24 | $75.3M | $176.6M | ||
| Q3 24 | $7.2M | $565.3M | ||
| Q2 24 | $-39.0M | $617.7M | ||
| Q1 24 | $-100.7M | $171.9M |
自由现金流率BTSGPPC
| Q4 25 | 5.5% | 0.2% | ||
| Q3 25 | 2.8% | 5.8% | ||
| Q2 25 | 0.8% | 7.1% | ||
| Q1 25 | 2.9% | 0.6% | ||
| Q4 24 | 2.5% | 4.0% | ||
| Q3 24 | 0.2% | 12.3% | ||
| Q2 24 | -1.4% | 13.5% | ||
| Q1 24 | -3.9% | 3.9% |
资本支出强度BTSGPPC
| Q4 25 | 1.1% | 6.2% | ||
| Q3 25 | 0.5% | 3.8% | ||
| Q2 25 | 0.8% | 3.3% | ||
| Q1 25 | 0.6% | 2.2% | ||
| Q4 24 | 0.5% | 4.0% | ||
| Q3 24 | 0.7% | 1.9% | ||
| Q2 24 | 0.9% | 2.2% | ||
| Q1 24 | 0.8% | 2.3% |
现金转化率BTSGPPC
| Q4 25 | 3.00× | 3.31× | ||
| Q3 25 | 1.93× | 1.34× | ||
| Q2 25 | 1.74× | 1.39× | ||
| Q1 25 | 3.44× | 0.43× | ||
| Q4 24 | 5.66× | 1.48× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | -0.76× | 2.20× | ||
| Q1 24 | — | 1.55× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
PPC
| Retail | $1.5B | 33% |
| Europe Reportable Segment | $1.4B | 31% |
| Food Service | $889.2M | 20% |
| Prepared Product | $332.8M | 7% |
| Product Export | $122.7M | 3% |
| Other Sales Channel | $96.0M | 2% |
| Other Product And Service | $79.7M | 2% |
| Related Party | $21.7M | 0% |
| Seara Meats B.V. | $18.9M | 0% |
| Penasul UKLTD | $10.3M | 0% |
| JBSUSA Food Company | $5.4M | 0% |
